Board of Directors
AbSorber
Related
Latest news
-
2011-10-31
Clinical use of XM-ONE® was highlighted at a symposium at the annual American Society of Histocompatibility and Immunogetetics (ASHI) meeting in New Orleans -
2011-05-11
New study confirms that XM-ONE® identifies kidney transplant recipients at increased risk for acute rejection. -
2011-04-10
AbSorber to host a Scientific Symposium at the American Transplant Congress in Philadelphia, PA -
2011-02-10
AbSorber and Olerup SSP has signed an exclusive distribution agreement for the Brazilian market, the world's second largest transplantation market after the US. Partner in Brazil is Genese Produtos Diagnosticos Ltda in Sao Paulo.
Board of Directors
Jan Eriksson
Chairman of the Board
Jan has more than 30 years senior executive experience in the pharmaceutical industry. He has held international leadership positions within Novartis, including President of Novartis’ Nordic Operations, and has served on several Boards in the biotech area.
Jan Holgersson
MD, PhD, Founder and Inventor. Assoc. Professor, Member of the Board.
Dr. Holgersson is a transplant immunologist and Associate Professor of Molecular Immunology at the Sahlgrenska University Hospital in Gothenburg. He has been involved in several international research programs and is also the founder of two other biomedical companies.